Alessandra Cirla

816 total citations
5 papers, 273 citations indexed

About

Alessandra Cirla is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alessandra Cirla has authored 5 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Alessandra Cirla's work include PARP inhibition in cancer therapy (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Alessandra Cirla is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Alessandra Cirla collaborates with scholars based in Italy and United Kingdom. Alessandra Cirla's co-authors include John Mann, Alessia Montagnoli, Gianluca Papeo, Elena Casale, Helena Posteri, Federico Riccardi Sirtori, Marina Ciomei, Daniele Donati, Antonella Isacchi and Alessandra Scolaro and has published in prestigious journals such as Cancer Research, Tetrahedron and Natural Product Reports.

In The Last Decade

Alessandra Cirla

5 papers receiving 270 citations

Peers

Alessandra Cirla

OC

MB

ONCOL

PHARM

EEE

Petra Grbčić Croatia

T. Prashanth India

Viraj B. Gandhi United States

Wen Jian Tang China

Ghada H. Elsayed Egypt

Aleem Fazal United States

Giuseppina Grisolia Italy

Grzegorz Adamczuk Poland

Mohamed Badr Egypt

Petra Grbčić Croatia

Alessandra Cirla

239 ×1.6

OC

206 ×1.8

MB

44 ×0.6

ONCOL

23 ×0.8

PHARM

10 ×0.4

EEE

Citations per year, relative to Alessandra Cirla Alessandra Cirla (= 1×) peers Petra Grbčić

Countries citing papers authored by Alessandra Cirla

Since Specialization

Citations

This map shows the geographic impact of Alessandra Cirla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Cirla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Cirla more than expected).

Fields of papers citing papers by Alessandra Cirla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Cirla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Cirla. The network helps show where Alessandra Cirla may publish in the future.

Co-authorship network of co-authors of Alessandra Cirla

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Cirla. A scholar is included among the top collaborators of Alessandra Cirla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Cirla. Alessandra Cirla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Papeo, Gianluca, Paolo Orsini, Nilla Avanzi, et al.. (2019). Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515. ACS Medicinal Chemistry Letters. 10(4). 534–538. 36 indexed citations

2.

Ardini, Elena, Patrizia Banfi, Nilla Avanzi, et al.. (2018). Abstract 4785: NMS-E668, a highly potent orally available RET inhibitor with selectivity towards VEGFR2 and demonstrated antitumor efficacy in multiple RET-driven cancer models. Cancer Research. 78(13_Supplement). 4785–4785. 2 indexed citations

3.

Papeo, Gianluca, Elena Casale, Alessia Montagnoli, & Alessandra Cirla. (2013). PARP inhibitors in cancer therapy: an update. Expert Opinion on Therapeutic Patents. 23(4). 503–514. 39 indexed citations

4.

Cirla, Alessandra, et al.. (2004). Synthesis of analogues of calicheamicin and neocarzinostatin chromophore. Tetrahedron. 60(18). 4019–4029. 8 indexed citations

5.

Cirla, Alessandra & John Mann. (2003). Combretastatins: from natural products to drug discovery. Natural Product Reports. 20(6). 558–558. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact